A recent study suggested that hypoxia-induced ANRIL promotes retinoblastoma cell resistance to cisplatin by promoting cell proliferation, inhibiting apoptosis, and upregulating drug resistance-related proteins [54]. This evidence concerns the gene CDKN2B-AS1 and retinoblastoma.